TransCode Therapeutics ( (RNAZ)) just unveiled an announcement. On December 19, 2025, TransCode Therapeutics appointed veteran life sciences executive Jack E. Stover to its board of directors, ...
The Ashes: Where did England go wrong? Ben Stokes responds to Noosa revelations & Archer is out No Balls: Snow Balls the Christmas Podcast Mayhem in Melbourne on bonkers Boxing Day England’s men win ...
BOSTON, Dec. 22, 2025 /PRNewswire/ -- TransCode Therapeutics, Inc. (NASDAQ: RNAZ), a clinical stage company pioneering immuno-oncology and RNA for the treatment of high risk and advanced cancer, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback